Bispham Barbara Harlin 4
4 · CRESCENT BIOPHARMA, INC. · Filed Dec 17, 2025
Insider Transaction Report
Form 4
Bispham Barbara Harlin
See Remarks
Transactions
- Award
Ordinary Shares
2025-12-15+12,422→ 12,422 total - Award
Ordinary Shares
2025-12-15+6,000→ 18,422 total - Award
Stock Option (Right to Buy)
2025-12-15+72,185→ 72,185 totalExercise: $13.21Exp: 2035-12-15→ Ordinary Shares (72,185 underlying)
Footnotes (2)
- [F1]Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Ordinary Shares. The RSUs shall vest in approximately equal three-month installments through the four-year anniversary of December 15, 2025, subject to the Reporting Person remaining continuously employed by or providing services to the Issuer or its subsidiaries from December 15, 2025 through each such vesting date.
- [F2]This Option represents a right to purchase shares of the Issuer's Ordinary Shares and vests with respect to 1/48th of the Option on each monthly anniversary of December 15, 2025, subject to the Reporting Person remaining continuously employed by or providing services to the Issuer or its subsidiaries from December 15, 2025 through each such vesting date.